We are live on ! Find out more
CNSP icon

CNS Pharmaceuticals
CNSP

1 hedge funds and large institutions have $1.44M invested in CNS Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1 → 1 (0)

0% less ownership

Funds ownership: 0% → 0% (-0%)

46% less capital invested

Capital invested by funds: $2.64M → $1.44M (-$1.2M)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$847K
2
TSS
Two Sigma Securities
New York
-$22K
3
IAN
Integrated Advisors Network
Texas
-$21K
4
UBS Group
UBS Group
Switzerland
-$9K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$908K – – –
Geode Capital Management
2
Geode Capital Management
Massachusetts
$159K – – –
BlackRock
3
BlackRock
New York
$60K – – –
Northern Trust
4
Northern Trust
Illinois
$48K – – –
Bank of New York Mellon
5
Bank of New York Mellon
New York
$44K – – –
VF
6
Virtu Financial
New York
$33K – – –
Citadel Advisors
7
Citadel Advisors
Florida
$32K – – –
Commonwealth Equity Services
8
Commonwealth Equity Services
Massachusetts
$29K – – –
State Street
9
State Street
Massachusetts
$27K – – –
HF
10
HRT Financial
New York
$24K – – –
Wells Fargo
11
Wells Fargo
California
$20K – – –
Cambridge Investment Research Advisors
12
Cambridge Investment Research Advisors
Iowa
$17K – – –
ACI
13
Alpha Cubed Investments
California
$16K – – –
Morgan Stanley
14
Morgan Stanley
New York
$8K – – –
Bank of America
15
Bank of America
North Carolina
$7K – – –
MIFH
16
Migdal Insurance & Financial Holdings
Israel
$3K – – –
CAL
17
Capital Analysts LLC
Pennsylvania
$1K – – –
SFP
18
Sterling Financial Planning
New Jersey
$1K – – –
IAN
19
Integrated Advisors Network
Texas
– -$21K – –
Renaissance Technologies
20
Renaissance Technologies
New York
– -$847K – –
TSS
21
Two Sigma Securities
New York
– -$22K – –
UBS Group
22
UBS Group
Switzerland
– -$9K – –

CNSP Hedge Fund Activity: Q3 2021 in Review

1 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in CNS Pharmaceuticals (CNSP) for Q3 2021, worth a combined $1.44M — down 46% from $2.64M a quarter earlier.

Fund positioning in CNSP was balanced in Q3 2021: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

The largest seller was Renaissance Technologies, cutting an estimated $847K.

  • 1 institutional investor held CNS Pharmaceuticals (CNSP) as of Q3 2021, unchanged from Q2 2021.
  • Funds reported $1.44M of CNS Pharmaceuticals stock for Q3 2021, down 46% quarter-over-quarter.
  • 0 funds opened new CNS Pharmaceuticals positions in Q3 2021 and 0 closed out.
  • The largest CNS Pharmaceuticals seller in Q3 2021 was Renaissance Technologies, an estimated $847K sold.

Based on aggregated 13F filings for Q3 2021.